Navigation Links
Stryker Announces Additional $500 Million Share Repurchase Program and Declares a 20% Increase in Quarterly Dividend
Date:12/8/2010

KALAMAZOO, Mich., Dec. 8, 2010 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that its Board of Directors has increased its dividend by 20% by declaring a quarterly dividend of $0.18 per share payable on January 31, 2011, to shareholders of record at the close of business on December 31, 2010.  

Stryker also announced today that its Board of Directors has authorized the Company to repurchase an additional $500 million of its common stock.  The manner, timing and amount of any purchases will be determined by the Company's management based on their evaluation of market conditions, stock price and other factors and will be subject to regulatory considerations.  Purchases may be made from time to time in the open market, in privately negotiated transactions or otherwise.  

The strength of Stryker's balance sheet and considerable cash flow allow for the return of significant value to shareholders through both dividends and share repurchases while simultaneously making the necessary investments that will drive continued sales and earnings growth. Since the start of 2010, Stryker has returned approximately $238 million to shareholders through dividends. In addition, under the existing $750 million share repurchase program, the Company has repurchased approximately $410 million as of December 7, 2010, of which approximately $300 million was purchased since the beginning of the fourth quarter.

"Our strong performance in 2010 has allowed us to both meaningfully boost our R&D spending, while also continuing our pattern over the last few years of consistently and significantly increasing our dividend," said Stephen P. MacMillan, Chairman, President and Chief Executive Officer of Stryker. "The 20% dividend increase, coupled with the additional share repurchase authorization resulting from our strong cash flow generation, positions us well to continue to increase shareholder value."

Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care.  The Company provides innovative orthopaedic implants as well as state-of-the-art medical and surgical equipment to help people lead more active and more satisfying lives.  For more information about Stryker, please visit www.stryker.com.


'/>"/>
SOURCE Stryker Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
2. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
3. Stryker Announces Acquisition of Privately-Held Porex Surgical
4. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
5. Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010
6. Stryker to Host Conference Call on October 19, 2010
7. Stryker to Present at Investor Conference
8. Stryker to Host Conference Call on July 20, 2010
9. Stryker Declares a $0.15 Per Share Quarterly Dividend
10. Stryker Facilities Earn LEED® Certifications
11. Stryker Enters Strategic Marketing Agreement with Acuitec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec. 9, 2016  Axovant Sciences Ltd. (NYSE: ... company focused on the treatment of dementia, today ... a Phase 2b trial evaluating treatment with intepirdine ... with donepezil plus placebo in people with mild-to-moderate ... of intepirdine to treatment was associated with reduced ...
(Date:12/8/2016)... -- KEY FINDINGS ... Patient warming and cooling devices offer ... lowering the risks of neurological disorders post cardiac arrests, rapid ... warming systems can be segmented into convective warming system, surface ... the stay at hospitals thus, lowering the healthcare costs by ...
(Date:12/8/2016)... Inc. (NYSE: DPLO) has been recognized by the Detroit Free ... To learn more about Diplomat,s career opportunities, visit ... ... ... a research firm specializing in organizational health and workplace improvement. The ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 09, 2016 , ... Even with breast cancer ... greatly in recent years. This can be attributed to the improvement in breast ... equally distributed. In response, Mediaplanet’s latest, cross-platform edition of “Breast Cancer Care” spotlights ...
(Date:12/10/2016)... ... December 10, 2016 , ... Denver-based humanitarian aid organization, ... war—babies and toddlers. , The situation in Syria continues to worsen—deadly weapon explosions ... and dying from disease. The situation is intensifying with winter coming and airstrikes ...
(Date:12/9/2016)... ... , ... Cellairis is a worldwide mobile device and computer repair franchise that ... and Samsung Galaxy devices with premium parts and accessories. Cellairis has recently set-up ... accessibility for customers. While customers do their shopping, Cellairis can accomplish a number of ...
(Date:12/9/2016)... ... 09, 2016 , ... Sober College, the game-changing dual diagnosis ... of the Sober College Robert Pfeifer Memorial Learning Center at its location in ... attended by an overwhelming amount of alumni, family, colleagues and friends of Sober ...
(Date:12/9/2016)... ... 09, 2016 , ... MEDI+SIGN®, a provider of fully-automated patient ... solution for Emergency Departments (ED) has been added to their portfolio. Housed in ... rooms, and with a simplified pallet of information available to the patient, the ...
Breaking Medicine News(10 mins):